Foreign Companies
in India Yearbook and CD-Rom features leading
international companies trading in India;
subsidiaries, representative offices, joint
ventures, associated companies and
franchises.....More
Angiotech’s patent for
Taxus stent revoked by
UK Court of Appeal,
(partially) upheld by
Dutch District Court
By a decision of 16
January 2006, 1 the
Court of Appeal in the
UK confirmed an
earlier decision of
the Patents Court 2
...
--------------------------------------------------------------------------------------------------------------------
CAFC dismisses IBEC
claim
The US Court of
Appeals for the
Federal Circuit has
ruled in a complex
case regarding the
ownership of a patent
used in Amgen’s drug
...
--------------------------------------------------------------------------------------------------------------------
Court blocks Lilly
leak
United States The US
District Court for the
Eastern District of
New York has granted
Eli Lilly and
Company’s plea to
issue a permanent ...
--------------------------------------------------------------------------------------------------------------------
Court invalidates
Lovenox patent
French pharmaceutical
company Sanofi-Aventis
has lost its patent
suit against Amphastar
Pharmaceuticals Inc
and Teva
Pharmaceutical
Industries Ltd. The
lawsuit revolved
around a patent
--------------------------------------------------------------------------------------------------------------------
EPLA blocked by
European Parliament’s
Legal Service
The European
Parliament’s Legal
Service has decided
that the European
Patent Litigation
Agreement (EPLA) is
not up to the
standards of European
law. The ...
--------------------------------------------------------------------------------------------------------------------
Exploding the chimera
myth
The 1,000 or so
mitochondria that
power the cells of all
living animals,
including humans, are
creatures in their own
right. Each tiny blob
comes ...
--------------------------------------------------------------------------------------------------------------------
GSK pays out US$35
million to settle
Wellbutrin dispute
United States
According to Watson
Pharmaceuticals,
GlaxoSmithKline (GSK)
has agreed to pay
US$35m in order to
settle patent
litigation relating to
its Wellbutrin XR ...
--------------------------------------------------------------------------------------------------------------------
KV Pharmaceuticals
wins advertising suit
United States KV
Pharmaceuticals and
its generic drug
subsidiary Ethex Corp
have announced that
they have won a
seven-week court
battle against Solvay
Pharmaceuticals ...
--------------------------------------------------------------------------------------------------------------------
Market authorisation
filing application for
generic drug not
permitted until expiry
of the patent
With a decision issued
on 23 October 2006 in
interlocutory
injunction proceedings
instigated by
Norwegian company
Pronova Biocare A/S
against Italian
company Chiesi
Farmaceutici SpA, ...
--------------------------------------------------------------------------------------------------------------------
Mundipharma objection
upheld
The Court of First
Instance (CFI) has
annulled OHIM’s trade
mark decision in
Mundipharma AG v
Altana Pharma AG . In
1998 Altana applied
...
--------------------------------------------------------------------------------------------------------------------
Novartis continues
with lawsuit despite
mounting pressure
Novartis’s lawsuit
against the Indian
Government is to
continue despite
mounting pressure
calling for the
company to drop it. US
congressman Henry
Waxman recently ...
--------------------------------------------------------------------------------------------------------------------
Patent litigation
settlements – payments
in reverse
There comes a stage in
most pharmaceutical
patent litigation
actions between
innovators and
generics when it
crosses at least one
of the parties’ minds
that ...
--------------------------------------------------------------------------------------------------------------------
Pharma industry reacts
angrily to OFT’s call
for PPRS reform
The UK pharmaceutical
industry has opposed
the Office of Fair
Trading’s (OFT) report
that recommends that
the Pharmaceutical
Price Regulation
Scheme (PPRS) should
be reformed. ...
--------------------------------------------------------------------------------------------------------------------
The new EU Penalties
Regulation
A new EU Regulation on
financial penalties
for infringements
relating to marketing
authorisations granted
by the EMEA 1 (the
Penalties Regulation)
will be adopted ...
--------------------------------------------------------------------------------------------------------------------
Valuable rewards for
children’s medicines
January 2007 saw the
introduction of the
eagerly awaited
European paediatric
medicines legislation,
Regulation (EC) No
1901/2006 (Paediatric
Regulation). This new
law imposes
significant
obligations
